Elovl6 promotes nonalcoholic steatohepatitis

2012204 citationsJournal Articlebronze Open Access

Authors

Takashi Matsuzaka · University of Tsukuba

Ayaka Atsumi · University of Tsukuba

Rie Matsumori · University of Tsukuba

Nie Tang · University of Tsukuba

Haruna Shinozaki · University of Tsukuba

Noriko Suzuki‐Kemuriyama · University of Tsukuba

Motoko Kuba ·

Abstract

Hepatic long-chain fatty acid composition is a novel determinant in NASH development, and Elovl6 could be a potential therapeutic target for the prevention and treatment of NASH.

Topics & Keywords

Liver Disease Diagnosis and Treatment Diet, Metabolism, and Disease Lipid metabolism and biosynthesis

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Hepatology

Volume 56, Issue 6, pp. 2199-2208

DOI: 10.1002/hep.25932

Field-Weighted Citation Impact: 6.98